莱茵生物(002166.SZ)：1.65亿股限售股份将于9月5日解禁

Group 1 - The company, Rhine Biotech (002166.SZ), announced the lifting of restrictions on the issuance of non-publicly offered shares, allowing for the circulation of 165 million shares, which accounts for 22.31% of the total share capital [1] - The number of shareholders involved in this lifting of restrictions is one [1] - The shares will be available for public trading starting from September 5, 2025 [1]